We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+67.85%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$3B
AUM Growth
+$1.23B
Cap. Flow
+$649M
Cap. Flow %
21.63%
Top 10 Hldgs %
17.27%
Holding
1,306
New
485
Increased
132
Reduced
163
Closed
412

Top Sells

Rank Stock Value
1
CZR icon
Caesars Entertainment
CZR
+$6.08M
2
EHC icon
Encompass Health
EHC
+$5.83M
3
BC icon
Brunswick
BC
+$5.57M
4
BBWI icon
Bath & Body Works
BBWI
+$5.29M
5
GE icon
GE Aerospace
GE
+$5.21M

Sector Composition

Rank Sector Weight
1 Healthcare 4.18%
2 Consumer Discretionary 4.17%
3 Technology 2.63%
4 Energy 0.9%
5 Industrials 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAY
626
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$671K 0.02%
60,000
+4,000
+7% +$41.9K
BLCM
627
CALL
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$669K 0.02%
90,000
PLAY icon
628
PUT
Dave & Buster's
PLAY
$377M
$667K 0.02%
+50,000
New +$666K
CMA
629
DELISTED
Comerica
CMA
$662K 0.02%
17,400
+9,400
+118% +$328K
RADA
630
PUT
DELISTED
Rada Electronic Industries Ltd
RADA
$662K 0.02%
101,000
PFPT
631
DELISTED
Proofpoint, Inc.
PFPT
$657K 0.02%
+5,906
New +$675K
RADA
632
CALL
DELISTED
Rada Electronic Industries Ltd
RADA
$655K 0.02%
100,000
ENTA icon
633
Enanta Pharmaceuticals
ENTA
$366M
$652K 0.02%
+13,000
New +$673K
INVA icon
634
CALL
Innoviva
INVA
$1.55B
$639K 0.02%
45,700
-52,000
-53% -$707K
SRNE
635
CALL
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$628K 0.02%
+100,000
New +$383K
VTR icon
636
Ventas
VTR
$48B
$616K 0.02%
+16,800
New +$555K
BILI icon
637
Bilibili
BILI
$7.99B
$610K 0.02%
+13,168
New +$428K
PBFX
638
CALL
DELISTED
PBF LOGISTICS LP
PBFX
$608K 0.02%
+62,300
New +$572K
SNDX icon
639
PUT
Syndax Pharmaceuticals
SNDX
$1.69B
$593K 0.02%
+40,000
New +$609K
VRS
640
CALL
DELISTED
Verso Corporation
VRS
$592K 0.02%
+49,500
New +$648K
CORT icon
641
CALL
Corcept Therapeutics
CORT
$12.4B
$590K 0.02%
35,000
-17,500
-33% -$246K
CORT icon
642
PUT
Corcept Therapeutics
CORT
$12.4B
$590K 0.02%
35,000
-17,500
-33% -$246K
PFGC icon
643
Performance Food Group
PFGC
$18B
$584K 0.02%
+20,028
New +$521K
GGAL icon
644
CALL
Galicia Financial Group
GGAL
$7.99B
$582K 0.02%
+60,000
New +$512K
GGAL icon
645
PUT
Galicia Financial Group
GGAL
$7.99B
$582K 0.02%
+60,000
New +$512K
DDS icon
646
PUT
Dillards
DDS
$9.19B
$581K 0.02%
+22,500
New +$636K
MYGN icon
647
CALL
Myriad Genetics
MYGN
$270M
$567K 0.02%
+50,000
New +$710K
IRTC icon
648
iRhythm Holdings
IRTC
$3.85B
$565K 0.02%
+4,883
New +$538K
HA
649
CALL
DELISTED
Hawaiian Holdings, Inc.
HA
$562K 0.02%
+40,000
New +$545K
KRE icon
650
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
$557K 0.02%
+14,500
New +$530K

Similar funds

Caption Management's Q2 2020 Portfolio in Review

As of Q2 2020, Caption Management held 1,306 positions worth $3B, up 70% from $1.77B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Caption Management deployed $649M of net new capital in Q2 2020, opening 485 new positions and adding to 132 existing holdings. Its largest new stake was SolarEdge: 148,183 shares worth $20.6M.

By sector, the portfolio is most concentrated in Healthcare at 4.2% of assets, down from 4.9% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Caesars Entertainment, an estimated $6.08M trimmed.

  • Caption Management's largest Q2 2020 buy was SolarEdge: 148,183 shares worth $20.6M.
  • Caption Management added most to Wayfair in Q2 2020, an estimated $18.1M increase.
  • Caption Management's biggest Q2 2020 reduction was Caesars Entertainment, cutting an estimated $6.08M.
  • Caption Management fully exited Encompass Health in Q2 2020, selling an estimated $5.83M.
  • Caption Management's ten largest holdings make up 17% of its $3B portfolio in Q2 2020.
  • Caption Management opened 485 new positions and closed 412 in Q2 2020.
  • Caption Management's portfolio value rose 70% quarter-over-quarter to $3B.

Based on Caption Management's 13F filing for Q2 2020, filed 14 Aug 2020.